+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
New

Deluxe Corp (DLX) - Financial and Strategic SWOT Analysis Review

  • PDF Icon

    SWOT Analysis

  • 40 Pages
  • August 2026
  • GlobalData
  • ID: 4852441
Deluxe Corp (DLX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by the analyst to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

  • Business description - A detailed description of the company’s operations and business divisions.
  • Corporate strategy - Analyst’s summarization of the company’s business strategy.
  • SWOT Analysis - A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history - Progression of key events associated with the company.
  • Major products and services - A list of major products, services and brands of the company.
  • Key competitors - A list of key competitors to the company.
  • Key employees - A list of the key executives of the company.
  • Executive biographies - A brief summary of the executives’ employment history.
  • Key operational heads - A list of personnel heading key departments/functions.
  • Important locations and subsidiaries - A list and contact details of key locations and subsidiaries of the company.
  • Detailed financial ratios for the past five years - The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
  • Interim ratios for the last five interim periods - The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Deluxe Corp (Deluxe) is a provider of technology-enabled solutions, customized products, and services. The company offers marketing services and data analytics, business envelopes, business forms, office supplies, treasury management solutions, merchant services, promotional products, and marketing and promotional solutions. The company also provides online print service, transaction processing, medical payment exchange services, fraud and security services and online printing services. It serves various industries, including financial institutions, healthcare, hospitality, non-profit organizations, professional services, retail, insurance, entrepreneurs, small and medium, and enterprises. The company operates in the US, Canada and India. Deluxe is headquartered at Minneapolis, Minnesota, the US.

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
  • The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
  • The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
  • Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
  • Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
Gain key insights into the company for academic or business research.
  • Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
Note: Some sections may be missing if data is unavailable for the company

Table of Contents

Section 1 - About the Company
  • University of Texas MD Anderson Cancer Center - Key Facts
  • University of Texas MD Anderson Cancer Center - Key Employees
  • University of Texas MD Anderson Cancer Center - Key Employee Biographies
  • University of Texas MD Anderson Cancer Center - Major Products and Services
  • University of Texas MD Anderson Cancer Center - History
  • University of Texas MD Anderson Cancer Center - Company Statement
  • University of Texas MD Anderson Cancer Center - Locations And Subsidiaries
  • Head Office
  • Other Locations & Subsidiaries
  • Joint Venture
Section 2 - Company Analysis
  • Company Overview
  • University of Texas MD Anderson Cancer Center - Business Description
  • Business Segment: Auxiliary Income
  • Performance
  • Business Segment: Grants and Contracts
  • Performance
  • Business Segment: Net Patient Service Revenue
  • Performance
  • Business Segment: Net Professional Fees
  • Performance
  • Business Segment: Net Sales and Services of Educational Activities
  • Performance
  • Business Segment: Other Income
  • Performance
  • R&D Overview
  • University of Texas MD Anderson Cancer Center - Corporate Strategy
  • University of Texas MD Anderson Cancer Center - SWOT Analysis
  • SWOT Analysis - Overview
  • University of Texas MD Anderson Cancer Center - Strengths
  • University of Texas MD Anderson Cancer Center - Weaknesses
  • University of Texas MD Anderson Cancer Center - Opportunities
  • University of Texas MD Anderson Cancer Center - Threats
  • University of Texas MD Anderson Cancer Center - Key Competitors
  • University of Texas MD Anderson Cancer Center, Recent Deals Summary
Section 3 - Company’s Recent Developments
  • Jun 11, 2026: Novel Gene Therapy Platform Restores Muscle Function in Models of Duchenne Muscular Dystrophy
  • May 21, 2026: UT MD Anderson Appoints Albert Koong, M.D., Ph.D., Chief Scientific Officer
  • May 14, 2026: New Marker Aids Diagnosis for Aggressive Prostate Cancer
  • May 06, 2026: Scientists Find Blood-Based Biomarkers for Inflammatory Breast Cancer
  • Apr 28, 2026: UT MD Anderson Establishes Center for Cellular Language Intelligence With $10 Million Gift from Peggy and Carl Sewell
  • Mar 26, 2026: Two UT MD Anderson Researchers Elected AAAS Fellows
  • Mar 02, 2026: Allison Institute Announces Appointment of Four New Members
  • Jan 30, 2026: Institute for Data Science in Oncology Names Focus-Area Lead for Decision Analytics in Cancer Control
  • Dec 24, 2025: Researchers Identify Rb1 as a Predictive Biomarker for a New Therapeutic Strategy in Some Breast Cancers
  • Dec 09, 2025: Research from the Melnick lab on African ancestry lymphoma reaches the ASH Scientific Plenary Session
Section 4 - Appendix
  • Methodology
  • About the Analyst
  • Contact the Publisher
  • Disclaimer
List of Tables
  • University of Texas MD Anderson Cancer Center, Key Facts
  • University of Texas MD Anderson Cancer Center, Key Employees
  • University of Texas MD Anderson Cancer Center, Key Employee Biographies
  • University of Texas MD Anderson Cancer Center, Major Products and Services
  • University of Texas MD Anderson Cancer Center, History
  • University of Texas MD Anderson Cancer Center, Other Locations
  • University of Texas MD Anderson Cancer Center, Subsidiaries
  • University of Texas MD Anderson Cancer Center, Joint Venture
  • University of Texas MD Anderson Cancer Center, Key Competitors
  • University of Texas MD Anderson Cancer Center, Recent Deals Summary